Cargando…
Botulinum toxin associated with fissurectomy and anoplasty for hypertonic chronic anal fissure: A case-control study
BACKGROUND: Lateral internal sphincterotomy is still the approach of choice for the treatment of chronic anal fissure (CAF) with internal anal sphincter (IAS) hypertonia, but it is burdened by high-risk postoperative faecal incontinence (FI). Sphincter saving procedures have recently been reconsider...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8610929/ https://www.ncbi.nlm.nih.gov/pubmed/34877311 http://dx.doi.org/10.12998/wjcc.v9.i32.9722 |
_version_ | 1784603195306147840 |
---|---|
author | D'Orazio, Beatrice Geraci, Girolamo Famà, Fausto Terranova, Gloria Di Vita, Gaetano |
author_facet | D'Orazio, Beatrice Geraci, Girolamo Famà, Fausto Terranova, Gloria Di Vita, Gaetano |
author_sort | D'Orazio, Beatrice |
collection | PubMed |
description | BACKGROUND: Lateral internal sphincterotomy is still the approach of choice for the treatment of chronic anal fissure (CAF) with internal anal sphincter (IAS) hypertonia, but it is burdened by high-risk postoperative faecal incontinence (FI). Sphincter saving procedures have recently been reconsidered as treatments to overcome this risk. The most employed procedure is fissurectomy with anoplasty, eventually associated with pharmacological sphincterotomy. AIM: To evaluate whether fissurectomy and anoplasty with botulinum toxin injection improves the results of fissurectomy and anoplasty alone. METHODS: We conducted a case-control study involving 30 male patients affected by CAF with hypertonic IAS who underwent fissurectomy and anoplasty with V-Y cutaneous flap advancement. The patients were divided into two groups: Those in group I underwent surgery alone, and those in group II underwent surgery and a botulinum toxin injection directly into the IAS. They were followed up for at least 2 years. The goals were to achieve complete healing of the patient and to assess the FI and recurrence rate along with manometry parameters. RESULTS: The intensity and duration of post-defecatory pain decreased significantly in both groups of patients starting with the first defecation, and this reduction was higher in group II. Forty days after surgery, we achieved complete wound healing in all the patients in group II but only in 80% of the patients in group I (P < 0.032). We recorded 2 cases of recurrence, one in each group, and both healed with conservative therapy. We recorded one temporary and low-grade postoperative case of “de novo” FI. Manometry parameters reverted to the normal range earlier for group II patients. CONCLUSION: The injection of botulinum toxin A in association with fissurectomy and anoplasty with a V-Y advancement flap improves the results of surgery alone in patients affected by CAF with IAS hypertonia. |
format | Online Article Text |
id | pubmed-8610929 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Baishideng Publishing Group Inc |
record_format | MEDLINE/PubMed |
spelling | pubmed-86109292021-12-06 Botulinum toxin associated with fissurectomy and anoplasty for hypertonic chronic anal fissure: A case-control study D'Orazio, Beatrice Geraci, Girolamo Famà, Fausto Terranova, Gloria Di Vita, Gaetano World J Clin Cases Case Control Study BACKGROUND: Lateral internal sphincterotomy is still the approach of choice for the treatment of chronic anal fissure (CAF) with internal anal sphincter (IAS) hypertonia, but it is burdened by high-risk postoperative faecal incontinence (FI). Sphincter saving procedures have recently been reconsidered as treatments to overcome this risk. The most employed procedure is fissurectomy with anoplasty, eventually associated with pharmacological sphincterotomy. AIM: To evaluate whether fissurectomy and anoplasty with botulinum toxin injection improves the results of fissurectomy and anoplasty alone. METHODS: We conducted a case-control study involving 30 male patients affected by CAF with hypertonic IAS who underwent fissurectomy and anoplasty with V-Y cutaneous flap advancement. The patients were divided into two groups: Those in group I underwent surgery alone, and those in group II underwent surgery and a botulinum toxin injection directly into the IAS. They were followed up for at least 2 years. The goals were to achieve complete healing of the patient and to assess the FI and recurrence rate along with manometry parameters. RESULTS: The intensity and duration of post-defecatory pain decreased significantly in both groups of patients starting with the first defecation, and this reduction was higher in group II. Forty days after surgery, we achieved complete wound healing in all the patients in group II but only in 80% of the patients in group I (P < 0.032). We recorded 2 cases of recurrence, one in each group, and both healed with conservative therapy. We recorded one temporary and low-grade postoperative case of “de novo” FI. Manometry parameters reverted to the normal range earlier for group II patients. CONCLUSION: The injection of botulinum toxin A in association with fissurectomy and anoplasty with a V-Y advancement flap improves the results of surgery alone in patients affected by CAF with IAS hypertonia. Baishideng Publishing Group Inc 2021-11-16 2021-11-16 /pmc/articles/PMC8610929/ /pubmed/34877311 http://dx.doi.org/10.12998/wjcc.v9.i32.9722 Text en ©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
spellingShingle | Case Control Study D'Orazio, Beatrice Geraci, Girolamo Famà, Fausto Terranova, Gloria Di Vita, Gaetano Botulinum toxin associated with fissurectomy and anoplasty for hypertonic chronic anal fissure: A case-control study |
title | Botulinum toxin associated with fissurectomy and anoplasty for hypertonic chronic anal fissure: A case-control study |
title_full | Botulinum toxin associated with fissurectomy and anoplasty for hypertonic chronic anal fissure: A case-control study |
title_fullStr | Botulinum toxin associated with fissurectomy and anoplasty for hypertonic chronic anal fissure: A case-control study |
title_full_unstemmed | Botulinum toxin associated with fissurectomy and anoplasty for hypertonic chronic anal fissure: A case-control study |
title_short | Botulinum toxin associated with fissurectomy and anoplasty for hypertonic chronic anal fissure: A case-control study |
title_sort | botulinum toxin associated with fissurectomy and anoplasty for hypertonic chronic anal fissure: a case-control study |
topic | Case Control Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8610929/ https://www.ncbi.nlm.nih.gov/pubmed/34877311 http://dx.doi.org/10.12998/wjcc.v9.i32.9722 |
work_keys_str_mv | AT doraziobeatrice botulinumtoxinassociatedwithfissurectomyandanoplastyforhypertonicchronicanalfissureacasecontrolstudy AT geracigirolamo botulinumtoxinassociatedwithfissurectomyandanoplastyforhypertonicchronicanalfissureacasecontrolstudy AT famafausto botulinumtoxinassociatedwithfissurectomyandanoplastyforhypertonicchronicanalfissureacasecontrolstudy AT terranovagloria botulinumtoxinassociatedwithfissurectomyandanoplastyforhypertonicchronicanalfissureacasecontrolstudy AT divitagaetano botulinumtoxinassociatedwithfissurectomyandanoplastyforhypertonicchronicanalfissureacasecontrolstudy |